The Foundation supports research across basic, translational and clinical science to speed breakthroughs that can lead to the creation of new treatments and a better quality of life for people with Parkinson's disease.
Search or browse funded studies
Previously funded studies appear chronologically, with the most recent appearing first.
-
Research Grant, 2018Searching Brain Scan Data for Patterns of Activity Associated with Parkinson's Disease
Study Rationale:
There is a pressing need for Parkinson's disease (PD) biomarkers -- objective measures of disease -- that will enable early and accurate diagnosis and allow to track disease... -
Computational Science, 2018Brain-inspired Computer Analysis of Complex Parkinson's Disease Data
Study Rationale:
Clinical research as well as wearable devices and phone apps used by people with Parkinson's disease (PD) generate large volumes of data, such as genetic and imaging data and data on... -
LRRK2 Biology Consortium, 2017Describing the Structure and Function of LRRK2
Study Rationale:
Although leucine-rich repeat kinase 2 (LRRK2) is the greatest known genetic contributor to Parkinson's disease (PD), little is known about its structure and function. To better... -
Research Grant, 2017Inflammation in Parkinson's Disease
Study Rationale:
The contribution of inflammation to Parkinson's disease (PD) is increasingly being recognized. However, the stage of the disease in which inflammation is prevalent and/or important...
-
Research Grant, 2016Study of Alpha-synuclein in the Dorsal Neostriatum
Promising Outcomes of Original Grant:
In February 2013, Luk et al. published in Science that administration of synthetic alpha-synuclein into pre-formed fibrils in pre-clinical models was sufficient to... -
LRRK2 Biology Consortium, 2017Development of Nanobodies as Novel Tools to Characterize LRRK2 as a Potential Drug Target for Parkinson's Disease
Study Rationale:
Several genes play a crucial role in Parkinson's disease (PD). The most common genetic cause of PD is mutations in the gene encoding LRRK2, a very large and complex protein with...
Apply for a Grant
Our funding programs support basic, translational and clinical research from academia and industry.